Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Nat Commun. 2020 May 29;11(1):2662. doi: 10.1038/s41467-020-16142-7.
Nat Commun. 2020.
PMID: 32471999
Free PMC article.
Clinical Trial.